Compared to a negative-low level, a moderate-very high level of ASPH, ADAM12, activated SRC, and MMPs correlated with curtailed overall survival (OS) of pancreatic cancer patients (log-rank test, ps < 0.001) (Fig. 6f–j). The gene discussed is SRC; the disease is pancreatic neoplasm.